Tenofovir Disoproxil Fumarate (TDF) + Lamivudine (3TC) Tablets are among the most widely prescribed antiretroviral (ARV) medicines used in the treatment of HIV-1 infection. This fixed-dose combination forms the nucleoside reverse transcriptase inhibitor (NRTI) backbone in many recommended HIV treatment regimens worldwide and continues to be included in international treatment guidance.
Cordium Pharmaceuticals Pvt. Ltd. is a reliable Indian pharmaceutical exporter supplying high-quality Tenofovir Disoproxil 300 mg + Lamivudine 300 mg Tablets to regulated and semi-regulated international markets, including:
π°πͺ Kenya | π³π¬ Nigeria | π¬π Ghana | π΅π Philippines | π»π³ Vietnam | π¦πͺ UAE | πΈπ¦ Saudi Arabia | πΊπΏ Uzbekistan | π°πΏ Kazakhstan | πΏπ¦ South Africa | πΊπΈ USA* | π¬π§ UK*
Subject to applicable regulatory approvals and market authorization requirements.
Mechanism of Action of Tenofovir Disoproxil + Lamivudine Tablets
Tenofovir Disoproxil and Lamivudine belong to the Nucleoside/Nucleotide Reverse Transcriptase Inhibitor (NRTI) class of antiretroviral medicines.
1. Tenofovir Disoproxil Fumarate (TDF)
Acts as a nucleotide reverse transcriptase inhibitor.
Converted inside the body into tenofovir diphosphate, its active form.
Competes with natural nucleotides during viral DNA synthesis.
Causes premature DNA chain termination, preventing HIV replication.
2. Lamivudine (3TC)
Converted intracellularly into lamivudine triphosphate.
Inhibits HIV reverse transcriptase.
Stops viral DNA synthesis by terminating the DNA chain.
Helps reduce viral replication and viral load.
Combined Effect
Together, Tenofovir Disoproxil + Lamivudine provide dual inhibition of HIV reverse transcriptase, significantly lowering viral replication. They are commonly used with a third antiretroviral agent such as an integrase inhibitor, according to treatment guidelines.
Uses of Tenofovir Disoproxil + Lamivudine Tablets
These tablets are indicated for:
HIV-1 infection treatment in adults and adolescents
First-line antiretroviral therapy (ART) as part of combination treatment
Long-term HIV viral suppression
Reducing progression to AIDS
Supporting immune recovery through increased CD4 cell counts
Helping reduce HIV transmission risk when viral suppression is maintained
Treatment should always be prescribed and monitored by qualified healthcare professionals.
Benefits of Tenofovir + Lamivudine Tablets
WHO guideline-supported NRTI backbone for many ART regimens
Proven efficacy against HIV-1
Convenient fixed-dose combination
High patient adherence
Globally accepted formulation
Suitable for public health HIV programs
Manufactured under stringent quality standards
Export Markets Served by Cordium Pharmaceuticals Pvt. Ltd.
Cordium Pharmaceuticals is expanding the global supply of high-quality antiretroviral medicines to healthcare providers, government tenders, NGOs, distributors, hospitals, and international procurement agencies across:
Kenya
Nigeria
Ghana
Philippines
Vietnam
UAE
Saudi Arabia
Uzbekistan
Kazakhstan
South Africa
USA (subject to regulatory compliance)
UK (subject to regulatory compliance)
Our export services include:
WHO-GMP quality manufacturing
Third-party manufacturing
Private label manufacturing
Contract manufacturing
International documentation support
Export-ready packaging
Bulk institutional supply
Timely global logistics
Why Choose Cordium Pharmaceuticals Pvt. Ltd.?
Experienced pharmaceutical exporter from India
Consistent product quality
Competitive international pricing
Regulatory documentation support
Reliable global supply chain
Customized export solutions
Dedicated support for distributors and importers